VRXAW — VERAXA BIOTECH AG
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 19 SEC-registered investment managers reported holding VRXAW (VERAXA BIOTECH AG) in their latest 13F filings, with a combined reported value of $773.23K across 6.67M shares. That is +7.7% by share count (+416.88K shares) versus the previous quarter, while reported value moved -41.2%. Ownership is concentrated: the five largest holders account for 81.0% of reported value and the top ten for 93.1%.
Compared with the prior quarter, 4 opened new positions, 5 added to existing stakes, 3 trimmed, 12 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of VERAXA BIOTECH AG (VRXAW) include Yorkville Advisors Global, LP, LMR Partners LLP, ARISTEIA CAPITAL, L.L.C., ranked by reported 13F value among the 31 institutional holders on this page.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 19 | 6.67M | $773.23K | +7.7% |
| Q2 2026 | 27 | 9.09M | $1.01M | — |
Over the 2 quarters shown, institutional share counts decreased 27% in aggregate (Q2 2026 → Q3 2026).
Top Institutional Holders (Q3 2026) — 19 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 309.90K | $387.37K | 0.35% | New | |
| 1.62M | $97.17K | 0.01% | Add | |
| 995.49K | $59.83K | 0.00% | Reduce | |
| 875.00K | $52.59K | 0.00% | Hold | |
| 485.66K | $29.19K | 0.00% | Hold | |
| 434.90K | $26.14K | 0.00% | Add | |
| 352.47K | $24.67K | 0.00% | Add | |
| 269.66K | $16.21K | 0.00% | Add | |
| 238.40K | $14.33K | 0.00% | Reduce | |
| 200.00K | $12.02K | 0.02% | New | |
| 183.65K | $11.04K | 0.00% | Hold | |
| 175.00K | $10.52K | 0.00% | New | |
| 154.95K | $9.30K | 0.00% | New | |
| 100.00K | $6.01K | 0.00% | Hold | |
| 100.00K | $6.01K | 0.00% | Hold | |
| 98.36K | $5.91K | 0.00% | Hold | |
| 75.00K | $4.51K | 0.00% | Reduce | |
| 6.95K | $418 | 0.00% | Add | |
| 194 | $12 | 0.00% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.60M | $176.58K | 0.01% | New | |
| 1.09M | $120.13K | 0.00% | New | |
| 1.06M | $116.38K | 0.00% | New | |
| 976.08K | $115.67K | 0.00% | New | |
| 875.00K | $96.51K | 0.00% | New | |
| 658.14K | $72.59K | 0.00% | New | |
| 485.36K | $53.53K | 0.00% | New | |
| 350.26K | $43.78K | 0.00% | New | |
| 253.21K | $27.93K | 0.00% | New | |
| 200.00K | $22.06K | 0.00% | New | |
| 193.61K | $21.36K | 0.00% | New | |
| 185.33K | $20.44K | 0.01% | New | |
| 183.65K | $20.26K | 0.00% | New | |
| 150.00K | $16.55K | 0.00% | New | |
| 142.08K | $15.67K | 0.00% | New | |
| 125.00K | $13.79K | 0.00% | New | |
| 102.75K | $11.33K | 0.00% | New | |
| 100.00K | $11.03K | 0.00% | New | |
| 100.00K | $11.03K | 0.00% | New | |
| 98.36K | $10.85K | 0.00% | New | |
| 59.99K | $6.62K | 0.00% | New | |
| 43.67K | $4.82K | 0.00% | New | |
| 19.89K | $2.19K | 0.00% | New | |
| 25.57K | $2.00K | 0.00% | New | |
| 10.27K | $1.13K | 0.00% | New |
New Positions (Q3 2026)
- Yorkville Advisors Global, LP 309.90K sh · $387.37K
- Kepos Capital LP 200.00K sh · $12.02K
- PICTON MAHONEY ASSET MANAGEMENT 175.00K sh · $10.52K
- K2 PRINCIPAL FUND, L.P. 154.95K sh · $9.30K
Fully Exited (vs previous quarter)
- LMR Partners LLP sold 1.09M sh · $120.13K
- ARISTEIA CAPITAL, L.L.C. sold 976.08K sh · $115.67K
- AQR Arbitrage LLC sold 658.14K sh · $72.59K
- MILLENNIUM MANAGEMENT LLC sold 200.00K sh · $22.06K
- WHITEBOX ADVISORS LLC sold 193.61K sh · $21.36K
- Wealthspring Capital LLC sold 185.33K sh · $20.44K
- TENOR CAPITAL MANAGEMENT Co., L.P. sold 150.00K sh · $16.55K
- Lineage Point Capital LP sold 102.75K sh · $11.33K
- BERKLEY W R CORP sold 59.99K sh · $6.62K
- Schonfeld Strategic Advisors LLC sold 19.89K sh · $2.19K
- HRT FINANCIAL LP sold 25.57K sh · $2.00K
- SUSQUEHANNA INTERNATIONAL GROUP, LLP sold 10.27K sh · $1.13K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 |
|---|---|---|
| Yorkville Advisors Global, LP | 309.90K | — |
| CSS LLC/IL | 1.62M | 1.60M |
| Magnetar Financial LLC | 995.49K | 1.06M |
| Alberta Investment Management Corp | 875.00K | 875.00K |
| Clear Street Group Inc. | 485.66K | 485.36K |
| MMCAP International Inc. SPC | 434.90K | 125.00K |
| JPMorgan Chase & Co | 352.47K | 350.26K |
| Verition Fund Management LLC | 269.66K | 43.67K |
| BNP PARIBAS FINANCIAL MARKETS | 238.40K | 253.21K |
| Kepos Capital LP | 200.00K | — |
| Westchester Capital Management, LLC | 183.65K | 183.65K |
| PICTON MAHONEY ASSET MANAGEMENT | 175.00K | — |
| K2 PRINCIPAL FUND, L.P. | 154.95K | — |
| Context Capital Management, LLC | 100.00K | 100.00K |
| Hudson Bay Capital Management LP | 100.00K | 100.00K |
| Yakira Capital Management, Inc. | 98.36K | 98.36K |
| Shaolin Capital Management LLC | 75.00K | 142.08K |
| WOLVERINE ASSET MANAGEMENT LLC | 6.95K | 2.92K |
| LONGFELLOW INVESTMENT MANAGEMENT CO LLC | 194 | 194 |
| LMR Partners LLP | — | 1.09M |
FAQ
Which funds hold VRXAW?
As of 2026-Q3, 19 institutional funds reported holding VRXAW (VERAXA BIOTECH AG) in SEC 13F filings, with a combined reported value of $773.23K.
How many shares of VRXAW do institutions own?
13F filers reported 6.67M shares of VRXAW, worth $773.23K in aggregate at the end of 2026-Q3.
Is institutional ownership of VRXAW rising or falling?
Share counts moved +7.7% versus the prior quarter — accumulation.
Who are the top institutional holders of VRXAW?
The largest 13F holders are Yorkville Advisors Global, LP, LMR Partners LLP, ARISTEIA CAPITAL, L.L.C., CSS LLC/IL, AQR Arbitrage LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of VERAXA BIOTECH AG?
The major shareholders of VERAXA BIOTECH AG (VRXAW) by reported 13F value are Yorkville Advisors Global, LP, LMR Partners LLP, ARISTEIA CAPITAL, L.L.C., CSS LLC/IL, AQR Arbitrage LLC, among 31 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.